Becker's Hospital Review

69 CIO / HEALTH IT 16 numbers that show where Epic, Cerner, Meditech, Allscripts stand in EHR market share, performance By Jackie Drees E pic, Cerner, Allscripts and Meditech are four of the largest EHR vendors in the industry, making up a combined 77 percent of the overall market share. Here is a breakout of each vendor's stand- ing in 2021 EHR market share, according to the KLAS June 2021 EHR vendor "Com- plete Look" reports. For the reports, KLAS examined each vendor's performance and market share based on customer interviews and analyses. Epic • Maintains 31 percent of the hospital EHR market share and 42 percent of hospital beds • Combined overall product suite grade: B+ • Combined overall loyalty grade: A • Percent of customers satisfied: 94 percent • Percent of customers reporting deep differ- ent-vendor interoperability: 63 percent Cerner • Maintains 25 percent of the hospital EHR market share and 27 percent of hospital beds • Combined overall product suite grade: C • Combined overall loyalty grade: C+ • Percent of customers satisfied: 62 percent • Percent of customers reporting deep differ- ent-vendor interoperability: 28 percent Meditech • Maintains 16 percent of the hospital EHR market share and 15 percent of hospital beds • Combined overall product suite grade: B+ • Combined overall loyalty grade: A- • Percent of customers satisfied: 90 percent • Percent of customers reporting deep differ- ent-vendor interoperability: 10 percent Allscripts • Maintains 5 percent of the hospital EHR market share and 5 percent of hospital beds • Combined overall product suite grade: C- • Combined overall loyalty grade: C- • Percent of customers satisfied: 53 percent • Percent of customers reporting deep differ- ent-vendor interoperability: 18 percent n Why telehealth companies are betting on subscription services By Jackie Drees T elemedicine companies are pushing subscriptions as a main driver to build on the growth they have maintained among consumers due to the COVID-19 pandemic, according to a June 15 Guardian report. While the COVID-19 virus surged from February to April in 2020, insurance claims for telehealth visits ballooned to more than 12 million a month, according to the report. While the demand for telehealth has since dipped to 8.8 million claims a month, it is still well ahead of where it was in 2019. Virtual care companies such as Alpha Medical, a Silicon Valley-based startup, are looking to meet these demands with subscription services. An Alpha Medical subscription costs about $120 a year and offers unlimited messaging with a provider for health conditions ranging from therapy to birth control. Alpha's main demographic is "gig and part-time workers," freelancers and the uninsured, or the people that David Blumenthal, MD, presi- dent of the CommonWealth Fund, calls the "disenfranchised" from the U.S. healthcare system, according to the report. Alpha's target demographic is "symptomatic, to use medical terminol- ogy, of a deeper disease," Dr. Blumenthal told the Guardian. "And that disease is a systematic lack of insurance for about 30 million Americans." By targeting mid- to low-income patients, who have high-deductible insurance plans that require spending thousands of dollars up front before insurance kicks in, Alpha's subscriptions come off as less ex- pensive than traditional insurance, according to the report. n Mayo Clinic inks AI commercialization deal: 4 things to know By Jackie Drees R ochester, Minn.-based Mayo Clinic signed a multiyear collaboration with Pro Medicus focused on building out and commercializing the health imaging IT provider's artificial intelligence-powered re- search platform, the organizations said June 3. Four things to know: 1. Pro Medicus' U.S. subsidiary Visage Imag- ing will work with Mayo Clinic on the project. 2. Mayo Clinic will collaborate with Visage Imaging's AI Accelerator Program, which offers tools for data de-identification, col- lection, analysis and commercialization in research projects. 3. Mayo Clinic and Visage Imaging will facilitate both development and commercialization of the AI products using Visage's AI accelerator. 4. The organizations will focus on the Vis- age 7 platform, developing tools for the AI- powered imaging platform that support third-party collaborations and integrations into clinicians' desktops. n

• Cover